tuberculosis
Fosun Pharma Granted License For TB Alliance Drug
The public-private partnership between the Gates Foundation, TB alliance and Fosun Pharma aims to develop and commercialize a new TB drug in China.
China Halves TB Prevalence In Just Twenty Years
China has reduced tuberculosis prevalence by 50% over the past 20 years, five years ahead of the target set by a global partnership.
US$12 Million In Grants Awarded For Neglected Diseases
Japan's Global Health Initiative Technology Fund has committed US$12 million in grants for neglected diseases and a potential tuberculosis vaccine.
Takeda, MMV Partner To Study Anti-Malarial Compounds
Takeda Pharma will collaborate with Medicines for Malaria Venture to study two new anti-malarial compounds.
How Golden Staph Breaks Down Our Immune Defenses
A new study shows how golden staph identifies key immune cells and 'nukes' our body's immune response when it enters our skin.
Study: Bangladesh Makes Strides In Healthcare Despite Poverty
Despite its high poverty level, Bangladesh has achieved lower infant mortality rates compared to India, Pakistan and Nepal.
Eisai, Broad Institute Develop Treatment For NTDs And Tuberculosis
Eisai Co., Ltd. has entered into an agreement with the Broad Institute to develop new therapeutic agents for the treatment of neglected tropical diseases and tuberculosis.
More Work Needed In Myanmar On Drug-Resistant TB
A WHO report projects that Myanmar will have a US$22 million funding gap for tuberculosis (TB care) and control services.
New Drug Against Multidrug-Resistant Tuberculosis Developed
An international team of researchers has developed a promising new drug for the treatment of multidrug-resistant tuberculosis (TB).
